APP processing and cleavage are implicated in the hepatic fibrosis/hepatic stellate cell activation pathway, the liver X receptor/retinoid X receptor (LXR/RXR) activation pathway, the neuroinflammation signaling pathway, the interleukin 17 (IL-17) signaling pathway, and the atherosclerosis signaling pathway. Here, APP is linked to atherosclerosis.